13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$717.86B
−14% on the quarter before
Positions
6,686
667 new · 701 sold out
Top 10
17.5%
of the value
Est. gain
−$108.70B
on stocks held all quarter
Est. return
−15.1%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan International Research Enhanced Equity ETF~$4.15BNew · 0.0% → 0.6%+85,906,762 shares
- Microsoft~$2.17BAdded · 3.1% → 3.3%+8,436,186 shares
- Invesco Qqq TrCALL~$1.95BAdded · 0.2% → 0.4%+6,950,300 underlying
- Unitedhealth Group Inc~$1.80BAdded · 1.0% → 1.4%+3,498,084 shares
- Invesco Qqq TrPUT~$1.55BAdded · 0.3% → 0.5%+5,533,100 underlying
- Ishares 7-10 Year Treasury B~$1.41BAdded · 0.2% → 0.4%+13,811,962 shares
- Alphabet~$1.07BAdded · 0.9% → 1.0%+489,469 shares
- United Parcel Service Inc~$1.02BAdded · 0.4% → 0.5%+5,569,848 shares
- Ishares 3-7 Year Treasury Bo~$1.01BAdded · 0.0% → 0.2%+8,440,188 shares
- Ishares National Muni Bond ETF~$909.1MAdded · 0.0% → 0.2%+8,547,343 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$5.95BCut · 1.1% → 0.3%−15,782,000 underlying
- Jpmorgan Betabuilders Europe ETF~$4.17BCut · 1.2% → 0.6%−90,547,883 shares
- Vanguard Short-Term Bond ETF~$1.58BCut · 0.3% → 0.1%−20,551,758 shares
- Ishares TrPUT~$801.5MCut · 0.2% → 0.1%−7,207,100 underlying
- Ishares Short Treasury Bond~$659.0MCut · 0.1% → 0.0%−5,985,941 shares
- Financial Select Sector SPDR~$627.4MCut · 0.3% → 0.2%−19,948,434 shares
- Cerner Corp~$608.1MSold out · 0.1% → 0.0%−6,499,895 shares
- Invesco Qqq Trust Series 1~$584.3MCut · 0.2% → 0.1%−2,084,879 shares
- SPDR S&P 500 ETF TrCALL~$577.0MCut · 0.2% → 0.1%−1,529,600 underlying
- SPDR Gold TrPUT~$570.2MCut · 0.4% → 0.4%−3,384,600 underlying
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON · shares +10% · price −16.7% | 3.3% | $23.38B | −$4.25B | ||||||||
| SPDR S&P 500 ETF TrustFUND · shares −0.4% · price −16.5% | 3.0% | $21.81B | −$4.30B | ||||||||
| AppleCOMMON · shares −0.09% · price −21.7% | 2.4% | $17.31B | −$4.80B | ||||||||
| AmazonCOMMON · shares −2.0% · price −21.8% | 1.6% | $11.34B | −$3.16B | ||||||||
| Unitedhealth Group IncCOMMON · shares +21% · price +0.7% | 1.4% | $10.40B | +$61.3M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +5.9% · price −5.5% | 1.3% | $9.57B | −$529.2M | ||||||||
| AlphabetCOMMON · shares +6.7% · price −21.7% | 1.2% | $8.78B | −$2.28B | ||||||||
| Abbvie IncCOMMON · shares +3.7% · price −5.5% | 1.2% | $8.59B | −$484.1M | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares +4.1% · price +5.4% | 1.0% | $7.53B | +$372.7M | ||||||||
| AlphabetCOMMON · shares +17% · price −21.6% | 1.00% | $7.17B | −$1.69B | ||||||||
| Johnson & JohnsonCOMMON · shares +17% · price +0.2% | 0.75% | $5.40B | +$7.3M | ||||||||
| MastercardCOMMON · shares +0.5% · price −11.7% | 0.74% | $5.34B | −$706.4M | ||||||||
| TeslaCOMMON · shares +18% · price −37.5% | 0.72% | $5.19B | −$2.65B | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +0.7% · price −13.1% | 0.72% | $5.18B | −$779.0M | ||||||||
| Eli LillyCOMMON · shares −4.9% · price +13.2% | 0.70% | $5.02B | +$586.6M | ||||||||
| Nextera Energy IncCOMMON · shares −0.6% · price −8.6% | 0.70% | $5.00B | −$467.7M | ||||||||
| Coca Cola CoCOMMON · shares +11% · price +1.5% | 0.69% | $4.96B | +$64.4M | ||||||||
| ConocophillipsCOMMON · shares +14% · price −10.2% | 0.68% | $4.91B | −$489.3M | ||||||||
| Mcdonalds CorpCOMMON · shares +6.9% · price −0.2% | 0.68% | $4.85B | −$7.3M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares −1.0% · price −16.3% | 0.65% | $4.69B | −$909.8M | ||||||||
| Vanguard Total Bond MarketFUND · shares +23% · price −5.3% | 0.64% | $4.62B | −$210.0M | ||||||||
| Jpmorgan Betabuilders Europe ETFFUND · shares −49% · price −16.0% | 0.61% | $4.41B | −$842.2M | ||||||||
| Deere & CoCOMMON · shares +0.9% · price −27.9% | 0.58% | $4.17B | −$1.60B | ||||||||
| Bk Of America CorpCOMMON · shares +5.2% · price −24.5% | 0.58% | $4.16B | −$1.28B | ||||||||
| Jpmorgan International Research Enhanced Equity ETFFUND · shares New | 0.58% | $4.15B | — | ||||||||
| Total · 6,686 positions | 100% | $717.86B | −$108.70B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 4,823 stocks held throughout, down $108.70B (−15.1%).
- Eli Lilly+$586.6M+13%
- Bristol-Myers Squibb Co+$372.7M+5%
- Nu Hldgs Ltd35:1 split+$181.9M+1,596%
- Merck & Co Inc+$173.8M+11%
- Northrop Grumman Corp+$132.3M+7%
- Tesla−$2.65B−38%
- Amazon24:1 split−$3.16B−22%
- Microsoft−$4.25B−17%
- SPDR S&P 500 ETF Trust−$4.30B−16%
- Apple−$4.80B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 58 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |